Epigenetic modification of <i>CSDE1</i> locus dictates immune recognition of nascent tumorigenic cells
Jiadi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Huang(Guangdong Pharmaceutical University), Li Zhou(North Sichuan Medical University), Haizeng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yonghong Wan(McMaster University Medical Centre), Yabo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Haoran Chen(Fudan University), Keke Wei(Shandong University), Jie Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Zhang(Tianjin Medical University General Hospital), Huafeng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuying Liu(Tianjin University of Science and Technology), Zhenfeng Wang(Henan University), Ke Tang(Sun Yat-sen University), Dianheng Wang(Huazhong University of Science and Technology), Jingwei Ma(Huazhong University of Science and Technology), Nannan Zhou(Yunnan Agricultural University)
Cited by 32
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k